|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Jan 31, 2021
|
Q4 FY2019
As of Jan 31, 2020
|
Q4 FY2018
As of Jan 31, 2019
|
Q4 FY2017
As of Jan 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash, current | ||||||||||||||||||||
| Short-term investment | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepayment and other current assets | ||||||||||||||||||||
| Deferred cost - current | ||||||||||||||||||||
| Amounts due from related parties, current | ||||||||||||||||||||
| Assets held for sale, current | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||
| Long-term time deposit | ||||||||||||||||||||
| Long-term investments | ||||||||||||||||||||
| Investment in equity security | ||||||||||||||||||||
| Investment in equity securities | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Deferred cost - non-current | ||||||||||||||||||||
| Other non-current assets, net | ||||||||||||||||||||
| Assets held for sale, non-current | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Short-term loans and current portion of long-term loans | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Convertible promissory notes | ||||||||||||||||||||
| Contingent liabilities | ||||||||||||||||||||
| Deferred government grant, current | ||||||||||||||||||||
| Amounts due to a related party | ||||||||||||||||||||
| Liabilities held for sale, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current liabilities: | ||||||||||||||||||||
| Long-term loans | ||||||||||||||||||||
| Contingent liabilities non-current | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Deferred government grant, non-current | ||||||||||||||||||||
| Derivative liability - investor warrant | ||||||||||||||||||||
| Derivative liability - placement agent warrant | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Common stock ($0.0001 par value; 3,000,000,000 shares authorized; 2,465,452 and 1,465,214 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) * | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total equity attributable to shareholders | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...